A New Treatment Option for Patients with nmCRPC
Webinar from December 5, 2019
Sponsored by Bayer
The focus of this webinar is the introduction of a new treatment for non-metastatic castration-resistant prostate cancer (nmCRPC) within the prostate cancer treatment continuum.
- Jason P. Lott, MD, MHS, MSHP, FAAD
Director, Customer Interface Strategy
Data Generation and Observational Studies
- Jill R. Carbone, MBA
Executive Director, Prostate Marketing
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.